| Publication Date | Title | Author(s) |
| Dec-2021 | COVID-19 living evidence synthesis #8 (version 1): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, J; Patiño-Lugo, DF |
| May-2022 | COVID-19 living evidence synthesis #8 (version 11): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, J; Patiño-Lugo, DF |
| May-2022 | COVID-19 living evidence synthesis #8 (version 12): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Jun-2022 | COVID-19 living evidence synthesis #8 (version 13): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Jun-2022 | COVID-19 living evidence synthesis #8 (version 14): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Aug-2022 | COVID-19 living evidence synthesis #8 (version 15): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Sep-2022 | COVID-19 living evidence synthesis #8 (version 16): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Oct-2022 | COVID-19 living evidence synthesis #8 (version 17): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Nov-2022 | COVID-19 living evidence synthesis #8 (version 18): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Dec-2022 | COVID-19 living evidence synthesis #8 (version 19): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Jan-2022 | COVID-19 living evidence synthesis #8 (version 2): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
| Feb-2023 | COVID-19 living evidence synthesis #8 (version 21): What is the effectiveness of available COVID-19 vaccines in children and adolescents in general and specifically for variants of concern? | Flórez, ID; Velásquez-Salazar, P; Martínez, JC; Linkins, L; Abdelkader, W; Iorio, A; Lavis, JN; Patiño-Lugo, DF |
